DGAP-News: Cannovum AG
/ Key word(s): Miscellaneous
06.01.2022 / 08:40
The issuer is solely responsible for the content of this announcement.
Cannovum AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) shortens the Germany-wide delivery times for its cannabis products. From now on, delivery to every pharmacy throughout Germany will take place directly on the next working day if the order is placed by 12:30 pm.
The new logistics structures have been extensively tested and the pilot phase has been successfully completed with positive results. With this process optimization, Cannovum is also preparing for the upcoming requirements of the legalization of cannabis as a stimulant, which will require secure and reliable logistics on a completely different scale than before.
“Fast and reliable delivery times of narcotics are crucial for pharmacies. It is important to us to continuously improve the supply of cannabis-based medications to patients. Furthermore, optimizing our logistics processes is another step towards becoming a reliable partner for licensed cannabis specialty stores,” says Pia Marten, CEO of Cannovum AG.
Linda Rasch, IR & PR, Cannovum AG
Cannovum AG is the first German listed medical cannabis company. The shares are traded on the Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Through its subsidiary Cannovum Health eG, Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based in Berlin. The company focuses on the import of high-quality cannabinoid products, medical-scientific education and all-encompassing distribution for simplified and facilitated access to cannabis-based therapies.
For more information, visit www.cannovum.com
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Rheinsberger Str. 76/77|
|Phone:||+49 (0)30 3982 16360|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich|
|EQS News ID:||1265314|
|End of News||DGAP News Service|